Cargando…

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials

Introduction: Hypertension is one of the most common cardiovascular diseases, and the prevalence of hypertension continues to rise across the globe. National and international guidelines recommend angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), calcium channel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Rabindra Nath, Langade, Deepak, More, Shyam, Revandkar, Vaibhav, Birla, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695827/ https://www.ncbi.nlm.nih.gov/pubmed/34963839 http://dx.doi.org/10.7759/cureus.19822

Ejemplares similares

Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies
por: Srivathsan, Mayakalyani, et al.
Publicado: (2022)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats
por: Aritomi, Shizuka, et al.
Publicado: (2015)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
por: Afzal, Muhammad A, et al.
Publicado: (2023)

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
por: Nezu, Tomohisa, et al.
Publicado: (2018)

Effects of the N/L‐Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients With Chronic Kidney Disease (J‐CIRCLE Study)
por: Uchida, Shunya, et al.
Publicado: (2014)

“Feeling the Blues”: A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue
por: Pellegrini, James R, et al.
Publicado: (2021)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus
por: Mori, Yutaka, et al.
Publicado: (2014)

Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema
por: Shetty, Ranjan, et al.
Publicado: (2013)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021)

Preparation and evaluation of cilnidipine microemulsion
por: Tandel, Hemal, et al.
Publicado: (2012)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
por: Kario, Kazuomi, et al.
Publicado: (2021)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
por: Ardissino, Maddalena, et al.
Publicado: (2022)

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
por: Das, Arijit, et al.
Publicado: (2016)

Postpartum Use of Shavari Bar® Improves Breast Milk Output: A Double-Blind, Prospective, Randomized, Controlled Clinical Study
por: Birla, Amita, et al.
Publicado: (2022)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Exploring the Impact of Prior Beta-Blocker and Calcium Channel Blocker Usage on Clinical Outcomes in Critically Ill Patients With Sepsis: An Observational Study
por: Kumar, Sachin, et al.
Publicado: (2023)

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial(1)
por: Ogihara, Toshio, et al.
Publicado: (2014)

The Effect of Thiazide Diuretics on Blood Lipid Profile in Hypertensive Adults: A Meta-analysis of Randomized Controlled Trials
por: Akhtar, Faisal, et al.
Publicado: (2018)

Indomethacin-Induced Hypertensive Crisis
por: Dhungana, Bibek, et al.
Publicado: (2021)

Using a mobile health app to improve patients’ adherence to hypertension treatment: a non-randomized clinical trial
por: Volpi, Simiane Salete, et al.
Publicado: (2021)

Obstructive Sleep Apnea in Hypertension
por: Chaudhary, Shyam C, et al.
Publicado: (2023)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies
por: Ma, Gai-gai, et al.
Publicado: (2020)

The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan
por: Elhouderi, Eiman, et al.
Publicado: (2023)

Cardiopulmonary Arrest During Pregnancy: A Review Article
por: Pawar, Sujeet J, et al.
Publicado: (2023)

Bradycardia, Renal Failure, Atrioventricular-nodal Blocker, Shock, and Hyperkalemia Syndrome Diagnosis and Literature Review
por: Sattar, Yasar, et al.
Publicado: (2020)

Effect of an emergency department education and empowerment intervention on uncontrolled hypertension in a predominately minority population: The AHEAD2 randomized clinical pilot trial
por: Prendergast, Heather, et al.
Publicado: (2021)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2rtu3e9bhg25hjikg3tbop06lv